Cellebrite DI Total Liabilities

Latest as of December 2025: $454.53 Million USD

Cellebrite DI total liabilities. Based on the latest financial reports, Cellebrite DI (CLBT) has total liabilities worth $454.53 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Cellebrite DI asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Cellebrite DI (2019–2025)

Total liabilities of Cellebrite DI from 2019 to 2025. This chart illustrates how Cellebrite DI's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Cellebrite DI to see how much of total assets are deployed in long-term investments.

Cellebrite DI Competitors by Total Liabilities

The table below lists competitors of Cellebrite DI ranked by their total liabilities.

Company Country Total Liabilities
Rising Nonferrous Metals Share Co Ltd
SHG:600259
China CN¥4.19 Billion
Sims Metal Management Ltd
F:I8M
Germany €1.86 Billion
SSAB AB (publ)
ST:SSAB-A
Sweden Skr38.39 Billion
Ionic Digital Inc. Class A Common Stock
NASDAQ:IOND
USA $61.41 Million
CITY DEV.LTD.ADR/1 SD-50
F:CDE0
Germany €17.08 Billion
IAC Inc.
NASDAQ:IAC
USA $2.23 Billion
Shanghai Sinyang Semiconductor
SHE:300236
China CN¥1.70 Billion
Aalberts Industries NV
AS:AALB
Netherlands €1.96 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Cellebrite DI's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cellebrite DI balance sheet assets.

Liquidity & Leverage Metrics

Cellebrite DI Total Liabilities Ratios Explained

Cellebrite DI total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cellebrite DI's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cellebrite DI (2019–2025)

The table below shows the annual total liabilities of Cellebrite DI from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 $454.53 Million +28.20%
2024-12-31 $354.55 Million -28.90%
2023-12-31 $498.67 Million +51.38%
2022-12-31 $329.43 Million -20.26%
2021-12-31 $413.13 Million +37.44%
2020-12-31 $300.58 Million +35.76%
2019-12-31 $221.41 Million --

About Cellebrite DI

NASDAQ:CLBT USA Software - Infrastructure
Market Cap
$3.06 Billion
Market Cap Rank
#4700 Global
#1640 in USA
Share Price
$12.25
Change (1 day)
+0.99%
52-Week Range
$10.44 - $19.28
All Time High
$26.00
About

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more